Kathryn Tringale

I am interested in using advanced imaging to predict and quantify treatment-related toxicity. Specifically, I have a special interest in tumors of the CNS and understanding the neurotoxicity of radiotherapy using neuroimaging and neurocognitive assessments. My more recent research during residency has focused on applying these interests to the pediatric and lymphoma patient populations.